FTXH vs. BBP
Compare and contrast key facts about First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Virtus LifeSci Biotech Products ETF (BBP).
FTXH and BBP are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FTXH is a passively managed fund by First Trust that tracks the performance of the Nasdaq U.S. Smart Pharmaceuticals Index. It was launched on Sep 20, 2016. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. Both FTXH and BBP are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FTXH or BBP.
Key characteristics
| FTXH | BBP | |
|---|---|---|
| YTD Return | -2.22% | -11.29% |
| 1Y Return | -2.40% | -0.63% |
| 3Y Return (Ann) | 1.00% | -1.31% |
| 5Y Return (Ann) | 5.93% | 4.19% |
| Sharpe Ratio | -0.13 | 0.04 |
| Daily Std Dev | 12.54% | 22.61% |
| Max Drawdown | -32.11% | -44.32% |
| Current Drawdown | -8.17% | -18.36% |
Correlation
The correlation between FTXH and BBP is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
FTXH vs. BBP - Performance Comparison
In the year-to-date period, FTXH achieves a -2.22% return, which is significantly higher than BBP's -11.29% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FTXH vs. BBP - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is lower than BBP's 0.79% expense ratio.
Risk-Adjusted Performance
FTXH vs. BBP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FTXH vs. BBP - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.47%, while BBP has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.47% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.16% | 0.00% |
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
Drawdowns
FTXH vs. BBP - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum BBP drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for FTXH and BBP. For additional features, visit the drawdowns tool.
Volatility
FTXH vs. BBP - Volatility Comparison
The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 3.39%, while Virtus LifeSci Biotech Products ETF (BBP) has a volatility of 5.61%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than BBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.